Skip to main content
SpringerLink
Log in

Comparison of two formulations of intravenous lipid emulsions in pediatric intestinal failure

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

The effect of different types of lipid emulsion may guide therapy of patients with intestinal failure (IF) to limit morbidity such as intestinal failure-associated liver disease (IFALD).

Methods

A retrospective chart review of pediatric patients with IF who received soybean oil lipid emulsion (SL) or mixed oil lipid emulsion (ML) was performed. Data over 1 year were collected.

Results

Forty-five patients received SL and 34 received ML. There were no differences in the incidence (82 versus 74%, P = 0.35) or resolution (86 versus 92%, P = 0.5) of IFALD between the cohorts. The median dose of ML was higher compared to SL (2 versus 1 g/kg/day, P < 0.001). If resolved, IFALD resolved rapidly in the ML cohort compared to the SL cohort (67 versus 37 days, P = 0.01). Weight gain was higher in the ML compared to the SL cohort at resolution of IFALD or 1 year from diagnosis of IF (P = 0.009).

Conclusion

The administration of ML did not alter the incidence or resolution of IFALD compared to SL in pediatric IF. There was rapid resolution of IFALD and enhanced weight gain in the ML cohort compared to SL in pediatric IF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All data supporting the findings of this study are available within the paper.

References

  1. Wendel D, Cole CR, Cohran VC (2021) Approach to intestinal failure in children. Curr Gastroenterol Rep 23:8

    Article  PubMed  Google Scholar 

  2. Norsa L, Nicastro E, Di Giorgio A et al (2018) Prevention and treatment of intestinal failure-associated liver disease in children. Nutrients. https://doi.org/10.3390/nu10060664

    Article  PubMed  PubMed Central  Google Scholar 

  3. Modi BP, Galloway DP, Gura K et al (2022) ASPEN definitions in pediatric intestinal failure. JPEN J Parenter Enteral Nutr 46:42–59

    Article  PubMed  Google Scholar 

  4. Kelly DA (2006) Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130:S70–S77

    Article  CAS  PubMed  Google Scholar 

  5. Intralipid [package insert]. Uppsala, Sweden: Fresenius Kabi; 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020248s020lbl.pdf. Accessed 14 Apr 2023

  6. Anez-Bustillos L, Dao DT, Baker MA et al (2016) Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract 31:596–609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cober MP, Killu G, Brattain A et al (2012) Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr 160:421–427

    Article  CAS  PubMed  Google Scholar 

  8. SMOFlipid [package insert]. Uppsala, Sweden: Fresenius Kabi; 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207648s005lbl.pdf. Accessed 14 Apr 2023

  9. Raghu VK, Sevilla WMA, King DE et al (2022) Current practices in lipid emulsion utilization in the prevention and treatment of intestinal failure-associated liver disease: a survey of pediatric intestinal rehabilitation and transplant centers. JPEN J Parenter Enteral Nutr 46:1585–1592

    Article  CAS  PubMed  Google Scholar 

  10. Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59

    Article  PubMed  PubMed Central  Google Scholar 

  11. (2022) Growth Charts—WHO Child growth standards. https://www.cdc.gov/growthcharts/who_charts.htm#The%20WHO%20Growth%20Charts. Accessed 14 Apr 2023

  12. Goulet O, Antébi H, Wolf C et al (2010) A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 34:485–495

    Article  CAS  PubMed  Google Scholar 

  13. Muhammed R, Bremner R, Protheroe S et al (2012) Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 54:797–802

    Article  CAS  PubMed  Google Scholar 

  14. Diamond IR, Grant RC, Pencharz PB et al (2017) Preventing the progression of intestinal failure-associated liver disease in infants using a composite lipid emulsion: a pilot randomized controlled trial of SMOFlipid. JPEN J Parenter Enteral Nutr 41:866–877

    Article  CAS  PubMed  Google Scholar 

  15. Belza C, Wales JC, Courtney-Martin G et al (2020) An Observational study of smoflipid vs intralipid on the evolution of intestinal failure-associated liver disease in infants with intestinal failure. JPEN J Parenter Enteral Nutr 44:688–696

    Article  CAS  PubMed  Google Scholar 

  16. Navaratnarajah N, Girard G, Sant’Anna G, et al (2022) The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: a large single center experience. Clin Nutr ESPEN 49:289–294

    Article  PubMed  Google Scholar 

  17. Casson C, Nguyen V, Nayak P et al (2020) A Comparison of smoflipid® and intralipid® in the early management of infants with intestinal failure. J Pediatr Surg 55:153–157

    Article  PubMed  Google Scholar 

  18. Kulpins D, Pickney C, Garb M et al (2023) Neonatal intensive care unit mixed lipid emulsion use associated with reduced cholestasis at discharge in surgical patients. J Surg Res 287:1–7

    Article  PubMed  Google Scholar 

  19. Hudson AS, Tyminski N, Turner JM, Silverman JA (2023) Intestinal failure-associated liver disease and growth pre- and post-transition to a composite lipid emulsion. J Pediatr Gastroenterol Nutr 76:830–836

    Article  CAS  PubMed  Google Scholar 

  20. Wassef J, Lipkin E, Hardigan P, Duro D (2022) Trends in liver profile and nutrition outcomes in children undergoing intestinal rehabilitation using a mixed lipid injectable emulsion. Nutr Clin Pract 37:1180–1189

    Article  CAS  PubMed  Google Scholar 

  21. Yu LJ, Anez-Bustillos L, Mitchell PD et al (2023) Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion. JPEN J Parenter Enteral Nutr 47:30–40

    Article  CAS  PubMed  Google Scholar 

  22. Lam CKL, Church PC, Haliburton B et al (2018) Long-term exposure of children to a mixed lipid emulsion is less hepatotoxic than soybean-based lipid emulsion. J Pediatr Gastroenterol Nutr 66:501–504

    Article  CAS  PubMed  Google Scholar 

  23. Sanchez SE, Braun LP, Mercer LD et al (2013) The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. J Pediatr Surg 48:573–578

    Article  PubMed  Google Scholar 

  24. Rollins MD, Ward RM, Jackson WD et al (2013) Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg 48:1348–1356

    Article  PubMed  Google Scholar 

  25. Nehra D, Fallon EM, Carlson SJ et al (2013) Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr 37:498–505

    Article  CAS  PubMed  Google Scholar 

  26. Levit OL, Calkins KL, Gibson LC et al (2016) Low-dose intravenous soybean oil emulsion for prevention of cholestasis in preterm neonates. JPEN J Parenter Enteral Nutr 40:374–382

    Article  CAS  PubMed  Google Scholar 

  27. Memon N, Hussein K, Hegyi T et al (2019) Essential fatty acid deficiency with SMOFlipid reduction in an infant with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr 43:438–441

    Article  CAS  PubMed  Google Scholar 

  28. Carey AN, Rudie C, Mitchell PD et al (2019) Essential fatty acid status in surgical infants receiving parenteral nutrition with a composite lipid emulsion: a case series. JPEN J Parenter Enteral Nutr 43:305–310

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Tina Findley, DO, reviewed the manuscript and provided support through the Summer Research Program at UTHealth McGovern Medical School.

Funding

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacy Services, Children’s Memorial Hermann Hospital - Texas Medical Center, 6411 Fannin Street, Houston, TX, 77030, USA

    Mamta Naik

  2. Short Bowel Syndrome Therapy and Rehabilitation (STAR) Team, McGovern Medical School, Texas Medical Center, The University of Texas Health Science Center at Houston and Children’s Memorial Hermann Hospital, Houston, TX, USA

    Mamta Naik, John Chapman, Allison L. Speer & Essam Imseis

  3. Department of Pediatrics, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA

    Alexandria Lawrence

  4. Department of Pediatrics, Division of Neonatal-Perinatal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA

    Allison Davidson & John Chapman

  5. Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA

    Dalya Ferguson & Allison L. Speer

  6. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA

    Essam Imseis

Authors
  1. Mamta Naik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexandria Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allison Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dalya Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Allison L. Speer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Essam Imseis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Alexandria Lawrence, Mamta Naik, and Dalya Ferguson. The first draft of the manuscript was written by Alexandria Lawrence and Mamta Naik and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mamta Naik.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naik, M., Lawrence, A., Davidson, A. et al. Comparison of two formulations of intravenous lipid emulsions in pediatric intestinal failure. Pediatr Surg Int 40, 97 (2024). https://doi.org/10.1007/s00383-024-05674-4

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00383-024-05674-4

Keywords

Search

Navigation